1 result(s) for BKM120
|PI Name||Protocol #||Title|
|Kathleen Kemmer||IRB00009076||A phase III randomized, double blind, placebo controlled study of BKM120 with fulvestrant, in postmenopausal women with hormone receptor-positive HER2-negative AI treated, locally advanced or metastatic breast cancer who progressed on or after mTOR inhibitor based treatment|
You may also qualify for Phase 1 Program trials.
For more information: